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Cell delivery to the pathological intervertebral disc (IVD) has significant therapeutic potential for
enhancing IVD regeneration. The development of injectable biomaterials that retain delivered cells,
promote cell survival, and maintain or promote an NP cell phenotype in vivo remains a significant
challenge. Previous studies have demonstrated NP cell e laminin interactions in the nucleus pulposus
(NP) region of the IVD that promote cell attachment and biosynthesis. These findings suggest that
incorporating laminin ligands into carriers for cell delivery may be beneficial for promoting NP cell
survival and phenotype. Here, an injectable, laminin-111 functionalized poly(ethylene glycol) (PEG-
LM111) hydrogel was developed as a biomaterial carrier for cell delivery to the IVD. We evaluated the
mechanical properties of the PEG-LM111 hydrogel, and its ability to retain delivered cells in the IVD
space. Gelation occurred in approximately 20 min without an initiator, with dynamic shear moduli in the
range of 0.9e1.4 kPa. Primary NP cell retention in cultured IVD explants was significantly higher over 14
days when cells were delivered within a PEG-LM111 carrier, as compared to cells in liquid suspension.
Together, these results suggest this injectable laminin-functionalized biomaterial may be an easy to use
carrier for delivering cells to the IVD.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Intervertebral disc (IVD) degeneration contributes to disability
and symptomatic pain in affected individuals, and affects more
than half the US population at some point in their lifetime [1]. A
number of biological and anatomical changes are associated with
IVD degeneration, initially occurring in the nucleus pulposus (NP),
where degeneration is characterized by decreased cellularity,
decreased water content and loss of proteoglycan deposition in the
extracellular matrix (ECM) [2]. These changes in matrix composi-
tion coincide with the loss of a distinct cell population derived from
the embryonic notochord [3,4]; therefore, it has been hypothesizedal Engineering, 136 Hudson
ke.edu (L.A. Setton).
All rights reserved.that notochordal cell disappearance may be an initiating or
contributing factor to degenerative disc disease [5e7]. Since cur-
rent surgical treatments of disease resulting from disc degeneration
often do not restore IVD function [8] and can lead to increased
mechanical load and adjacent segment disease [9], there exists
significant interest in tissue engineering strategies for regenerating
the IVD.
Cell transplantation to the IVD has been performed clinically
[10], and aims to repopulate the disc with cells capable of synthe-
sizing new ECM to restore function to the diseased IVD. In animal
models of IVD regeneration, reimplantation of autologous disc cells
or stem cells has been shown to delay degeneration, as measured
by histological and radiographic changes [8,11e16]. Although the
need for a biomaterial carrier to improve cell retention immediately
after delivery has been demonstrated [17], few studies have eval-
uated the role of the carrier in long-term cell survival and retention
[16]. Injectable materials for cell delivery to the IVD have received
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tissue engineering approach for enhancing IVD regeneration.
Numerous hydrogels derived from natural components of the ECM,
including fibrin [17e19], hyaluronan [11,20,21], and collagen
[12,22,23], and natural biopolymers such as chitosan [24e26] have
been investigated as carriers for cell delivery to the disc. Although
these naturally derivedmaterials mimicmany features of the native
ECM, few peptide and protein functionalized scaffolds have been
developed that can direct biological responses of cells for NP
regeneration. The development of injectable biomaterials that
support cell retention, cell survival and maintain or promote an NP
cell phenotype in vivo remains a significant challenge.
Laminins are heterotrimeric ECM proteins consisting of a, b, and
g polypeptide chains that mediate a number of cellular functions
including adhesion, survival, migration and differentiation [27,28].
Previous studies in our laboratory have demonstrated NP cell e
laminin interactions that are unique to the immature disc, sug-
gesting that laminins may be important contributors to NP-specific
cell biology. Immunohistochemistry and flow cytometry results
demonstrated higher expression levels of the laminin a5 and g1
chains, laminin receptors (integrin a3, a6, b4 subunits, CD239), and
related binding proteins in NP cells as compared to cells from the
adjacent anulus fibrosus [29e31]. Additional studies have shown
that soft, laminin containing ECM substrates promote immature NP
cell morphology, cellecell interactions, and proteoglycan synthesis
for cells of the NP [32]. Finally, immature porcine NP cells adhere to
laminins in higher numbers as compared to cells from the adjacent
anulus fibrosus [33]. These findings provide support for known
interactions between immature NP cells and multiple laminin
isoforms that regulate NP cell biology, and suggest that a soft,
laminin-functionalized hydrogel may be desirable for promoting
primary NP cell phenotype and biosynthesis.
Poly(ethylene glycol) (PEG) hydrogels have been widely used in
tissue engineering applications since they are hydrophilic polymers
that readily allow for incorporation of biological signals derived from
the native ECM [34]. The non-fouling nature of PEG, combined with
its tunable mechanical properties, allows for control over biological
signal presentation and hydrogel stiffness. Therefore, full length
ECM-derived proteins, including collagen, fibrinogen and laminin,
have been covalently coupled to PEG hydrogels for a variety of tissue
engineering applications and shown to influence cell behavior in
three dimensions [35e38]. The majority of these studies rely on
photocrosslinking of acrylate functional groups on PEGylated pro-
teins and PEG-multiacrylates to form three-dimensional hydrogels;
however, conjugate addition between free thiols and PEG-acrylate or
PEG-vinylsulfone allows gelation to occur in situ under physiological
conditions [39,40] without the need for UV light. This chemistry
enables a utility of the PEG-crosslinking hydrogel that is more suit-
able for the delivery of cells in vivo.
The objective of this work was to develop an injectable laminin-
functionalized PEG hydrogel with tunable mechanical properties,
and to assess its potential use as a carrier for cell-based IVD
regeneration. We describe here the synthesis and characterization
of a PEG-laminin (PEG-LM111) conjugate with functional acrylates
for crosslinking, and subsequent hydrogel formation via the addi-
tion of PEG-dithiol and PEG-octoacrylate. Additionally, we describe
the generation of luciferase expressing primary NP cells, and the
delivery of these cells to the disc space within our injectable
biomaterial carrier.
2. Materials & methods
2.1. PEG-laminin (PEG-LM111) conjugate synthesis and characterization
Laminin-111 (LM111, Trevigen, Gaithersburg, MD) was PEGylated with acrylate-
PEG-N-hydroxysuccinimide (Ac-PEG-NHS, MW ¼ 10 kDa, Creative PEGworks,Winston Salem, NC) to introduce functional acrylate groups for crosslinking. LM111
was dialyzed into a 0.1 M sodium bicarbonate buffer, pH 8.5, and diluted to a con-
centration of 2 mg/ml. Ac-PEG-NHS was solubilized in ice cold 0.1 M sodium bicar-
bonate buffer and added to LM111 solution at 10:1, 25:1, 100:1 or 500:1 M ratio of Ac-
PEG-NHS to LM111. Reactions were carried out for 2 h at room temperature. Precursor
PEG-LM111 conjugate solutions were dialyzed against 1x PBS to remove any unreacted
Ac-PEG-NHS. LM111 concentration in each PEG-LM111 conjugate precursor solution
was determined by measuring the absorbance at 280 nm, and conjugates were stored
at 80 C until further use.
A TNBS (2,4,6-trinitrobenzene sulfonic acid) assay [41] was modified to measure
the free amino groups in each PEG-LM111 conjugate compared to unmodified
protein, and to estimate the degree of modification due to Ac-PEG-NHS substitution.
Each PEG-LM111 conjugate and unmodified LM111were diluted to 500 mg/ml in PBS,
whichwas determined to bewithin the linear range for LM111 using this assay. TNBS
was diluted to 0.01% in 0.1 M sodium bicarbonate buffer, pH 8.5. Samples (PEG-LM111
conjugates or LM111) were mixed with 0.01% TNBS at a 1:1 ratio by volume, and
incubated for 30 min at 60 C. Absorbance was measured at 340 nm using a
microplate reader (Enspire, PerkinElmer, Waltham, MA) and used to calculate de-
gree of modification (%): 100 x {1((A340 PEG-LM111)/(A340 LM111))}. An ANOVA
was performed to analyze degree of modification, using Tukey’s post hoc test
(p < 0.01, n ¼ 3) to detect differences between PEG-LM111 conjugates synthesized
with different Ac-PEG-NHS to LM111 ratios.
2.2. Cell isolation and culture
Cells isolated from the porcine NP have a unique notochordal phenotype, and
were therefore used to evaluate both PEG-LM111 conjugate bioactivity and for
in vitro and in vivo cell delivery experiments. Lumbar spines were obtained from pigs
shortly after sacrifice (L1eL5, 4e7 months, Nahunta Pork Outlet, Raleigh NC). Cells
were isolated from the NP regions of IVDs by enzymatic digestion [42] and cultured
in monolayer for 3e7 days in culture media (Ham’s F-12 media supplemented with
10% fetal bovine serum (FBS), 10 mM HEPES, 100 U/ml penicillin, and 100 U/ml
streptomycin) prior to experiments. For control studies, cells from a lung epithelial
cell line (WI26VA4, ATCC No. CCL-95-1) were cultured in monolayer (37 C, 5% CO2,
20% O2) with media changes every 3e4 days (Dulbecco’s Modified Eagle’s Medium
supplemented with 10% FBS, 10 mM HEPES) prior to experiments.
2.3. PEG-LM111 conjugate bioactivity
To evaluate cell attachment to PEG-LM111 conjugates, wells of 96-well plates
were coated with PEG-LM111 conjugates synthesized with various ratios of Ac-PEG-
NHS to LM111 at 5, 10, and 25 mg/ml LM111 by overnight incubation at 4 C. Coated
wells were blocked with 3.75% bovine serum albumin (BSA) for 3 h at 37 C to
prevent non-specific adhesion. LM111 coated wells and BSA only coated wells were
used as positive and negative controls, respectively. Porcine NP cells in monolayer
were detached using trypsin/EDTA, washed with trypsin neutralizing solution and
resuspended in serum free media. Cells (4000 cells/well) were allowed to adhere to
the LM111 and PEG-LM111 conjugate coated surfaces for 2 h at 37 C. Wells were
rinsed with serum free media to remove non-adherent cells, and the number of
adherent cells per well was determined using CellTiterGlo (Promega Corporation,
Madison, WI) luminescent cell viability reagent. Differences in attachment numbers
to PEG-LM111 conjugates at 25 mg/ml LM111 were detected via ANOVAwith Tukey’s
post hoc test (p < 0.05, n ¼ 3 separate cell isolations).
To determine if PEG-LM111 conjugate maintains the ability to induce ERK acti-
vation upon cell adhesion, wells of 6-well tissue culture plates were coated by
overnight incubation at 4 C with 20 mg/ml LM111 or PEG-LM111 that had been
PEGylated at the highest ratio of Ac-PEG-NHS shown to promote cell attachment at
levels similar to native protein. All wells were blocked with 3.75% BSA to prevent
non-specific adhesion. Cells from a lung epithelial cell line WI26VA4 (ATCC No. CCL-
95-1) that had been cultured to confluence, then serum deprived for 24 h, were
seeded onto LM111 or PEG-LM111 conjugate coated surfaces (500,000 cells/well).
WI26VA4 cells cultured in suspension served as negative controls. After 30 and
60 min, cells were lysed with ice cold cell lysis buffer containing protease and
phosphatase inhibitors (RIPA, Cell Signaling Technologies, Danvers, MA), spun down
at 4 C, and cell lysates were stored at 80 C. Total protein concentration in each of
the cell lysates was determined using the BCA Protein Assay (Thermo Scientific,
Waltham, MA). All lysates were diluted in cell lysis buffer to equal concentrations of
total protein and a phospho-ERK ELISA (Cell Signaling Technologies) was used to
detect relative levels of phosphorylated ERK.
2.4. PEG-LM111 hydrogel synthesis and mechanical properties
PEG-octoacrylate (20 kDa, Creative PEGworks) and PEG-dithiol (3.4 kDa, Crea-
tive PEGworks) were dissolved separately in PEG-LM111 conjugate (25:1 Ac-PEG-
NHS to LM111) solutions and PBS to final concentrations of 10% (w/v) PEG and 0,
100, or 500 mg/mL PEG-LM111 conjugate (25:1 Ac-PEG-NHS to LM111). All samples
were tested in oscillatory shear under physiological conditions (37 C, pH 7.4) in a
humidified atmosphere. Briefly, appropriate volumes of PEG-octoacrylate and PEG-
dithiol solutions that had been dissolved in PEG-LM111 conjugate solution were
Fig. 1. PEG-LM111 conjugate synthesis and degree of modification (%). (A) Conjugation
of PEG molecules to laminin via amine reactive NHS groups. (B) Degree of modification
of LM111 calculated from LM111 and PEG-LM111 conjugate absorbance at 340 nm
using TNBS assay. Degree of modification increased with increasing molar excess of Ac-
PEG-NHS in the PEGylation reaction (mean  SEM, n ¼ 3, conditions labeled with
different letters significantly different, p < 0.01).
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thiol groups. Solutions were mixed and immediately pipetted onto the center of a
test platen (25 mm diameter) within the test chamber of a controlled stress
rheometer (AR-G2, TA Instruments, New Castle, DE). The upper platen was lowered
to a gap thickness of 1 mm and oscillatory shear was applied (u¼ 0.5 Hz, g0¼ 0.05).
The evolution of storage (G0) and loss (G00) moduli were recorded over time, and used
to calculate the complex shear modulus (jG*j). Gelation time was determined by the
crossover of G0 and G00 for each hydrogel formulation. Differences in gelation time
and steadyestate complex shear modulus amongst gel formulations were detected
by ANOVA with Tukey’s post hoc test (p < 0.05, n ¼ 5 per formulation).
2.5. Generation of luciferase expressing primary NP cells
To generate transduction media, VSV-G pseudotyped lentivirus driving consti-
tutive expression of the luciferase2 transgene (obtained from pGL4.50; Promega,
Madison, WI) under control of the EF1a promoter (LVE-LUC2) was prepared in 293T
cells using the standard calcium phosphate precipitation technique [43] and stored
at 80 C until further use. LVE-LUC2 was thawed and supernatant was centrifuged
through a 100 kDa MWCO filter (EMD Millipore, Billerica, MA). A concentrated LVE-
LUC2 vector (80x concentration) was mixed with NP culture media (5 ml concen-
trated virus per ml media) supplemented with 4 mg/ml polybrene (SigmaeAldrich,
St. Louis, MO). Primary porcine NP cells were isolated as described above, plated at a
density of 40,000 cells/cm2 in culture media, and cells were allowed to adhere for
24 h. Culturemediawas then aspirated fromNP cells and replacedwith transduction
media. After 24 h, LVE-LUC2 containingmediawas aspirated and fresh culturemedia
was added. Luciferase expressing porcine NP (NP-luc) cells were cultured in
monolayer with media changes every 2e3 days.
2.6. Cell delivery to IVD motion segments
The effect of PEG-LM111 biomaterial on cell retention and survival in the IVD
was evaluated in an organ culture model. Rat tails (n ¼ 8 Sprague Dawley, 200e
250 g, Charles River, Wilmington, MA) were harvested within 3 h of sacrifice, skin
and tendons were removed, and 7-8 IVD motion segments were obtained from each
animal (C1eC8). Disc motion segments were washed three times, and placed in
sterile petri dishes. A nucleotomy was performed by injecting air into the disc space
via a 27G needle. PEG-LM111 precursor solution (10% PEG containing 1:1 acrylate to
thiol ratio, 500 mg/ml PEG-LM111 conjugate synthesized with 25:1 Ac-PEG-NHS to
LM111) was prepared as described above. NP-luc cells that had been cultured in
monolayer for at least 10 days were lifted and resuspended at a concentration of
106 cells/ml in PEG-LM111 precursor solution or PBS, and 10 ml was delivered to the
NP of individual caudal motion segments through a 27G needle. The needle was held
in place for 1 min following cell delivery to reduce leakage. Individual motion
segments were separated, placed in separate wells of a 12-well plate, and overlaid
with media. Motion segments receiving no additional injection (sham) and PEG-
LM111 precursor solution only were used as negative controls. All motion seg-
ments were cultured out to 14 days at 37 C, 5% CO2 and 20% O2 in culturemedia (F12
supplemented with 20% FBS, 100 U/ml penicillin, and 100 U/ml streptomycin) with
media changes every day.
2.7. Cell delivery to rat tail IVD
In vivo studies of cell persistence within the rat IVD were performed to test
proof-of-concept for use of the PEG-LM111 hydrogel as a carrier for NP-luc cells. NP-
luc cells were delivered to the rat tail IVD either in PEG-LM111 hydrogel, PEG-only
hydrogel (no PEG-LM111 conjugate) or PBS. Rats (Sprague Dawley, 200e250 g,
Charles River) were anesthetized with isoflurane, and a 3 cm incision was made on
the dorsal side of the tail to obtain access to the C3eC4, C4eC5 and C5eC6 disc
space. A nucleotomy was performed at the C3eC4 and C5eC6 levels of each tail
using a 25G needle, and the anulus fibrosus was closed with one 5-0 Vicryl suture
(Ethicon Inc., Somerville, NJ). Cells in PBS, cells in PEG-LM111 (PEG-octoacrylate and
PEG-dithiol, 500 mg/ml PEG-LM111 conjugate), and cells in PEG-only (PEG-octoa-
crylate and PEG-dithiol, no PEG-LM111 conjugate) were prepared as described
above. Using a Hamilton syringe with a 27G needle, 10 ml of cells in PEG-LM111, cells
in PBS, or cells in PEG-only was injected into the middle of the C3eC4 denucleated
disc space (n ¼ 2 per group). The C5eC6 disc space of the same tail received either
PEG-LM111 biomaterial only or nucleotomy only (sham). Skin was closed in an
interrupted manner using 4.0 nylon sutures. All procedures were approved by the
IACUC and were performed in accordance with Duke University guidelines.
2.8. Bioluminescent imaging
Bioluminescent imaging of cell culture plates, IVD motion segments or rats that
had received NP-luc cells was performed using an IVIS Kinetic, and signal in-
tensities were quantifiedwith Living Imaging software (PerkinElmer,Waltham,MA).
For in vitro evaluation of the stability of luciferase expression by NP-luc cells in
monolayer, NP-luc and control naïve NP cells were lifted at multiple time points
post transduction (day 4e35), counted and suspended in culture media. These cells
were added to separate wells of a 96 well black bottom tissue culture plate(5000 cells/well). Wells were supplemented with 150 mg/ml D-luciferin (Perki-
nElmer) and imaged 10 min after addition of D-luciferin (5 s exposure time). Cell
retention in rat motion segments was evaluated at multiple time points after in-
jection of NP-luc cells using bioluminescence imaging. To evaluate cell retention in
IVD motion segments, wells containing rat IVD motion segments were supple-
mented with 300 mg/ml D-luciferin and light emission was measured 2 min later
(30 s exposure time). For in vivo imaging, D-luciferin (150 mg/kg) was injected
intraperitoneally 15min before imaging, after which rats were anesthetized with 1e
3% isoflurane and imaged (5 min exposure time). For NP-luc cells cultured in
monolayer, total photons per second per cell was calculated from the total photons
in a defined region of interest (ROI) drawn over eachwell. An ANOVAwas performed
to analyze light emission (photons/sec/cell), using Tukey’s post hoc test (p < 0.05,
n¼ 3) to detect differences between time points. For cultured IVDmotion segments,
an oval ROI was drawn around the entire motion segment based on a photographic
image. Total photons within each ROI was obtained from the overlay luminescent
image. Differences amongst cell delivery vehicles and time post injection were
analyzed via two-factor ANOVA with Tukey’s post hoc test (p < 0.05, n ¼ 6).
3. Results
3.1. PEG-LM111 conjugate synthesis
PEG-LM111 conjugates with functional acrylate groups for
crosslinking were synthesized via amine reactive NHS groups
(Fig. 1A). Degree of LM111 modification, as measured by the reduc-
tion in number of reactive amines in each PEG-LM111 conjugate,
significantly increased with increasing ratios of Ac-PEG-NHS to
LM111 in the reaction solution (Fig. 1B). A minimum 25-fold molar
excess of Ac-PEG-NHS over LM111 in the PEGylation reaction was
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500-fold molar excess of Ac-PEG-NHS resulted in 39% LM111 modi-
fication,whichwas significantly higher (ANOVA, p< 0.001) than that
of PEG-LM111 conjugates synthesized at 10-fold, 25-fold or 100-fold
molar excess Ac-PEG-NHS over LM111.3.2. PEG-LM111 conjugate bioactivity
To determine the relationship between the degree of LM111
modification and level of cell attachment, porcine NP cell attach-
ment to PEG-LM111 conjugates with varying degrees of modifica-
tion was assessed. Results for NP cell adhesion to PEG-LM111
conjugates demonstrated decreased cell attachment with
increasing molar excess of Ac-PEG-NHS over LM111 used in con-
jugate synthesis, as compared to NP cell attachment to unmodified
LM111 (Fig. 2A). Cell attachment was significantly reduced (ANOVA,
p < 0.001) for conjugates synthesized with large molar excesses of
PEG (100:1 or 500:1); however, cell attachment numbers for PEG-
LM111 conjugate synthesized with a 25:1 ratio of Ac-PEG-NHS to
LM111 were greater than 89% of values for NP cell attachment to
native LM111. Therefore, PEG-LM111 conjugate synthesized at a 25-
fold molar excess of Ac-PEG-NHS over LM111, which corresponds to
6% degree of modification by TNBS, was used for all subsequent
experiments.
To further verify bioactivity of PEG-LM111 conjugate with a low
degree of modification, we investigated activation of the MAPK/
ERK signaling pathway subsequent to cell attachment to LM111 and
PEG-LM111 conjugate. Since it has been shown that cell attachment
to LM111 leads to ERK activation in a lung epithelial cell line
(WI26VA4) [44], we hypothesized that a PEG-LM111 conjugate
capable of maintaining levels of cell adhesion similar to that of
native LM111 would also support ERK phosphorylation. As shown
in Fig. 2B, LM111 induced a 3-fold increase in phosphorylated ERK
over cells cultured in suspension after 30 min and a 1.6-fold in-
crease after 60 min. PEG-LM111 conjugate induced similar levels
of phosphorylated ERK as compared to LM111 with 2.8-fold andFig. 2. Bioactivity of PEG-LM111 conjugates. (A) Porcine NP cells were allowed to attach to L
decreased with increasing molar excess Ac-PEG-NHS in the PEGylation reaction (cell attach
labeled with different letters significantly different, p < 0.04). (B) LM111 induced ERK activa
seeded onto LM111 and PEG-LM111 conjugate coated surfaces, or cultured in suspension. Aft
compared using ELISA.1.7-fold higher levels of ERK phosphorylation over negative con-
trols after 30 and 60 min, respectively.
3.3. PEG-LM111 hydrogel mechanical properties
When PEG-LM111 conjugate solution or PBS was mixed with
PEG-octoacrylate and PEG-dithiol under physiological conditions
(37 C, pH 7.4), hydrogels formed in less than 25min by the reaction
of thiols and acrylates, as measured by the point of crossover of G0
and G00 (Fig. 3A). For hydrogels containing 500 mg/ml PEG-LM111
conjugate, the gel point occurred in less than 14 min. PEG-only
(no PEG-LM111 conjugate) and PEG-LM111 hydrogel mechanical
properties continued to evolve for approximately 1 h. The final gel
stiffness (jG*j) increased with increasing concentrations of PEG-
LM111 conjugate in the precursor solution (Fig. 3B).
3.4. Cell delivery to IVD motion segments
To track cells following delivery to the IVD using in vivo biolu-
minescent imaging, it was necessary to verify that NP-luc cells
maintain luciferase expression for at least 4 weeks post trans-
duction. Luciferase expression in NP-luc cells cultured inmonolayer
increased approximately 3.5-fold from day 4 to day 35 post trans-
duction; however, there was no significant difference in expression
between day 24 and day 35 (ANOVA, p > 0.05) (Fig. 4).
Bioluminescence imaging was utilized to examine the effect of
PEG-LM111 hydrogel carrier on NP-luc cell retention and survival in
IVD motion segments. The total number of photons in a defined
region of interest (ROI) was quantified at multiple time points
following cell injection (Fig. 5B). Cell retention in IVD explants was
significantly higher (ANOVA, p < 0.001) over 14 days in culture
when cells were delivered within a PEG-LM111 hydrogel carrier, as
compared to cells in PBS (Fig. 5A). At 30 min post injection, biolu-
minescent signal was 13-fold higher when cells were delivered to
IVDs in PEG-LM111 biomaterial; however, signal rapidly decayed
over the first 24 h of culture for both groups. NP-luc cells in IVDM111 and PEG-LM111 conjugates for 2 h. NP cell attachment to PEG-LM111 conjugates
ment levels normalized to NP cells on 25 mg/ml LM111, mean  SEM, n ¼ 3, conditions
tion in a lung epithelial cell line. Cells from a lung epithelial cell line (WI26VA4) were
er 30 and 60 min, cells were lysed and levels of phosphorylated ERK in cell lysates were
Fig. 3. Rheometric characterization of PEG-LM111 hydrogels. (A) Gel point occurred in less than 25 min for hydrogels containing different concentrations of PEG-LM111 conjugate
(mean  SEM, n ¼ 5, conditions labeled with different letters significantly different, p < 0.04). (B) Final gel stiffness (jG*j) of PEG-LM111 hydrogels increased with increasing
concentration of PEG-LM111 conjugate in the precursor solution.
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14 days post injection.3.5. In vivo cell delivery to rat IVD
Preliminary studies were performed to determine if NP-luc cells,
delivered to the rat tail IVD in either PBS, PEG-LM111 hydrogel, or
PEG-only hydrogel, could be detected via in vivo imaging. Cells
could be detected in the disc space 15 min after intraperitoneal
injection of luciferin (Fig. 6). For all animals, maximum luminescent
signal did not exceed 1000 counts over a 5 min exposure time,
possibly due to a low number of delivered cells, low luciferase
expression levels, poor luciferin distribution to the tail, and signal
attenuation by the collagenous tail skin.Fig. 4. Luciferase activity in cultured porcine NP cells. NP cells transduced with
lentivirus encoding for firefly luciferase were cultured for 35 days post transduction. At
each time point, photons per second per cell was calculated from measured biolumi-
nescent intensity 10 min after addition of luciferin to the media (mean  SEM, n ¼ 3,
conditions labeled with different letters significantly different, p < 0.03).
Fig. 5. Cell retention in IVD motion segments. (A) NP-luc cells were delivered to rat
IVD motion segments and explants were cultured for 14 days. Cell retention, as
measured by total photons per motion segment, was higher for cells delivered in PEG-
LM111 biomaterial as compared to cells delivered in PBS (mean  SEM, n ¼ 6, con-
ditions labeled with different letters significantly different, p < 0.001). (B) Region of
interest (ROI) defined on photographic image of motion segment (top) used quantify
total photons per motion segment in overlay image (bottom). (C) Representative im-
ages of IVD motion segments 30 min and 7 days post cell injection within PEG-LM111
biomaterial carrier (top) or PBS (bottom).
Fig. 6. In vivo bioluminescent imaging 15 h after 1 106 NP-luc cells were injected into
the rat tail disc space. Luciferin (150 mg/kg) was injected intraperitoneally 15 min
before imaging. Rat was anesthetized with 2% isoflurane during imaging (5 min
exposure time).
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The goal of this work was to develop an injectable, laminin-
functionalized hydrogel as a biomaterial carrier for cell delivery
to the IVD. Laminin presenting substrates have previously been
shown to promote the morphology and phenotype of immature NP
cells in vitro, and to promote increased cell attachment and
elevated glycosaminoglycan synthesis for primary NP cells in cul-
ture [32,33]. For these reasons, a three-dimensional biomaterial
carrier presenting laminin was developed as a carrier for primary
NP cells. Conjugation of the laminin protein, LM111 to synthetic
PEGs was performed with varying levels of protein modification in
order to identify a formulation that could maintain LM111 func-
tionality, and appropriate cellelaminin interactions. Results
showed the degree of laminin modification increased with
increasing molar excess of Ac-PEG-NHS in the conjugate synthesis
reaction [45], up to a maximum value of 40% primary amine
modification with a 500-fold molar excess of Ac-PEG-NHS. Primary
NP cell adhesion to PEG-LM111 conjugates significantly decreased
with increasing degree of PEGylation, with no cells adhering to
PEG-LM111 conjugate with the highest degree of modification. This
finding was expected as PEGylation of therapeutic compounds has
been shown to modify their structure and bioactivity [45]. Never-
theless, low levels of PEGylation (up to 25:1 Ac-PEG-NHS to LM111)
did not significantly reduce NP cell adhesion to PEG-LM111 con-
jugates, nor inhibit MAPK/ERK activation upon binding to the
modified protein. This low level of laminin modification still
enabled the PEG-LM111 conjugate to participate in a gelation
crosslinking reaction that was shown to be effective in promoting
cell entrapment. Together, these findings demonstrate that LM111
PEGylation via a heterobifunctional Ac-PEG-NHS allows for the
additional of functional acrylates groups onto native LM111
without significantly altering the protein’s ability to mediate
cellular function.
PEG-LM111 conjugates were crosslinked to form hydrogels upon
the addition of PEG-octoacrylate and PEG-dithiol via a Michael type
addition reaction without the need for an initiator, as has been
shown for PEG hydrogels designed for protein delivery [39]. Gela-
tion occurred within 20 min under physiological conditions inde-
pendent of the concentration of PEG-LM111 conjugate in theprecursor solution. The reaction was thus considered to provide for
an acceptable working time for cell delivery in vivo since it allows
time for cell suspension and accurate needle placement within the
disc space [46]. The dynamic stiffness of PEG-LM111 hydrogels in
shear increased slightly fromw0.9 kPa tow1.5 kPawith increasing
concentration of PEG-LM111 conjugate in the precursor solutions,
all values that are only slightly lower than values reported previ-
ously for the dynamic shear moduli of human NP (7.4e19.8 kPa)
[47,48]. Stiffness can be readily manipulated to achieve a targeted
goal by modifying the amount of PEG within the crosslinked
hydrogel. In a prior report of PEG-laminin hydrogels crosslinked by
photopolymerization, hydrogel stiffness decreased with increasing
concentration of the PEG-laminin conjugate precursor solutions
[38], a finding that differs from that observed in the current study.
This difference likely reflects intrinsic differences between step-
growth and chain-growth polymerization reactions in the two
different systems; our finding suggests that high concentrations of
PEG-LM111 conjugate in the precursor solution reduces the num-
ber of non-idealities in the crosslinked hydrogel network, which
are introduced in hydrogels formed by Michael-type addition re-
actions at low PEG concentrations [49]. This is a feature that can be
modulated to achieve a targeted outcome through biomaterial
design if it should become desirable to modulate the porosity or
stiffness, for example, to achieve a specific set of biological out-
comes [50]. Here our goal was to obtain a material that retained
laminin functionality, provided good working characteristics, and
physical properties that approximated that of the native NP. Over-
all, these findings suggest this laminin-functionalized biomaterial
can provide an injectable carrier for delivering cells to the IVD.
Many biomaterials have been investigated as carriers for cell
delivery to the IVD in numerous animal models of disc degeneration
[17]. While solid scaffolds arewidely used to support IVD cell growth
ex vivo [51e53], we have focused in this study on injectable, in situ
polymerizing three-dimensional hydrogels that could maintain the
rounded phenotype for NP cells. Naturally derived biopolymers and
self-polymerizing biomaterials such as collagen, chitosan and fibrin
are most commonly utilized for NP regeneration, although the
physical properties and chemical composition of these biomaterials
is not easily manipulated [54]. Chemical crosslinking of alginate is
the most commonly used approach to promote a rounded pheno-
type for NP cells and is the standard for cell culture studies [55].More
recently, photocrosslinking of alginate has been proposed as ameans
to manipulate a three-dimensional matrix for NP cells [56], and a
self-assembling peptide hydrogel has been similarly investigated
[57]. Few injectable biomaterials have presented functional ECM li-
gands that can retain native NP cellematrix interactions and facili-
tate cell-mediated matrix remodeling, which may be important for
promoting long-term cell survival and biosynthesis.
While prior studies have established the importance of a
biomaterial carrier for improved cell transfer to the disc space
immediately following delivery [17], little is known of the role of
the biomaterial carrier in promoting long-term cell retention and
survival [16]. Studies were performed here to test for an ability of
the newly synthesized PEG-LM111 biomaterial to promote NP cell
retention and survival in the disc space, by following luciferase
expression for immature primary NP cells delivered via needle in-
jection to the disc space in an organ culture model. The optimized
PEG-LM111 hydrogel significantly improved primary NP cell
retention and survival as compared to cells delivered in an
uncrosslinked, liquid suspension. Thirty minutes after injection,
bioluminescent signal was 13-fold higher when cells were deliv-
ered in a PEG-LM111 biomaterial, suggesting that cell delivery in
the absence of a solid-setting carrier may result in dramatic cell loss
[17]. These findings suggest that an optimized PEG-LM111 hydrogel
is able to crosslink in situ and significantly improve upon the
A.T. Francisco et al. / Biomaterials 34 (2013) 7381e7388 7387retention of delivered cells. The PEG-LM111 hydrogel was unable to
inhibit complete cell loss, however, as cells continued to die or
migrate from the disc space over the first 24 h after delivery, likely
due to a high intra-discal pressure that induced extrusion through
the injection site. This highlights the need for annular repair
techniques in addition to biomaterials for cell delivery, or high-
strength crosslinked biomaterial carriers, that may need to be
employed to slow or eliminate cell loss following delivery [58].
Cell delivery to the disc space has been performed in animal
models of disc degeneration and in human subjects for more than a
decade [8]. Cell retentionwithin the disc space is difficult to follow in
the living subject, particularly for clinical studies that rely upon
minimal modification of delivered cells [31]. Much of the work
studying cell delivery to the disc space in animal models has relied
on histological techniques subsequent to animal sacrifice at specific
time points, which precludes in vivo assessment and longitudinal
tracking of cell therapy. In a recent study, investigators demonstrated
the feasibility of bioluminescence imaging for monitoring the
viability of luciferase expressing cells within the lumbar spine in a
rodent model up to 14 days after cell implantation [59]. Here, we
performed preliminary studies to determine if similar in vivo biolu-
minescent imaging could be used to track NP-luc cells delivered to
the rat caudal IVD. Although cells could be detected in the disc space
for up to 7 days following delivery, bioluminescent signal intensity
was extremely low even over long exposure times. Photon emission
at the tissue surface depends on the number of delivered cells, the
photon flux per cell (luciferin expression levels and luciferin avail-
ability), and the signal attenuation by the tissue [60]. Additionally,
intraperitoneal injection of luciferin may not be suitable for evalu-
ating luciferase expressing cells in the caudal discs and alternate
luciferin delivery routesmay need to be explored. Therefore, the very
low bioluminescent signals that we reported from in vivo imaging
are likely due to a combination of factors, including our delivery of
comparatively low cell numbers to the disc space, and other limita-
tions related to bioluminescence imaging.
5. Conclusions
We report here the development and characterization of an
injectable laminin-functionalized PEG hydrogel as a biomaterial
carrier for cell delivery to the IVD. The findings from this study
demonstrate the ability of PEG-LM111 hydrogels to crosslink under
physiological conditions without the need for an initiator. Addi-
tionally, delivery within our PEG-LM111 hydrogel significantly
improved primary NP cell retention in the disc space as compared
to cells delivered without a carrier in an organ culture model.
Bioluminescence imaging for evaluating the effect of our carrier on
persistence and viability of delivered cells in vivo merits further
investigation. In summary, these findings suggest that this laminin-
functionalized hydrogel may be a useful carrier for cell-based
strategies aimed at regenerating the IVD.
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